HOME > Detail View

Detail View

Six sigma in the pharmaceutical industry : understanding, reducing, and controlling variation in pharmaceuticals and biologics

Six sigma in the pharmaceutical industry : understanding, reducing, and controlling variation in pharmaceuticals and biologics (Loan 1 times)

Material type
단행본
Personal Author
Nunnally, Brian K. McConnell, John S.
Title Statement
Six sigma in the pharmaceutical industry : understanding, reducing, and controlling variation in pharmaceuticals and biologics / Brian K. Nunnally, John S. McConnell.
Publication, Distribution, etc
Boca Raton :   CRC Press ,   c2007.  
Physical Medium
204 p. : ill. ; 24 cm.
ISBN
9781420054392 (pbk. : alk. paper) 1420054392 (pbk. : alk. paper)
Content Notes
The enormous initial mistake -- The origins of six sigma -- Evolution -- Revolution -- Paradox -- Action and reaction -- Close enough or on target? -- Make more-- faster! -- Case studies -- The camera always lies -- Keeping it simple -- Why use control charts? -- Average and range control charts -- Origins and theory -- Charts for individuals -- Practical considerations -- Improving laboratories -- Beyond compliance.
Bibliography, Etc. Note
Includes bibliographical references and index.
Subject Added Entry-Topical Term
Drugs -- Quality control. Six sigma (Quality control standard) Pharmaceutical industry. Drug Industry. Technology, Pharmaceutical -- methods. Efficiency, Organizational. Quality Control.
000 01787camuu22003734a 4500
001 000045398197
005 20071108154510
008 070125s2007 flua b 001 0 eng
010 ▼a 2007003468
015 ▼a GBA718965 ▼2 bnb
020 ▼a 9781420054392 (pbk. : alk. paper)
020 ▼a 1420054392 (pbk. : alk. paper)
035 ▼a (KERIS)REF000013066893
040 ▼a DNLM/DLC ▼c DLC ▼d NLM ▼d UKM ▼d BAKER ▼d BTCTA ▼d C#P ▼d YDXCP ▼d DLC ▼d 211009
042 ▼a pcc
050 0 0 ▼a RS192 ▼b .N862 2007
082 0 0 ▼a 338.4/76151 ▼2 22
090 ▼a 338.476151 ▼b N972s
100 1 ▼a Nunnally, Brian K.
245 1 0 ▼a Six sigma in the pharmaceutical industry : ▼b understanding, reducing, and controlling variation in pharmaceuticals and biologics / ▼c Brian K. Nunnally, John S. McConnell.
260 ▼a Boca Raton : ▼b CRC Press , ▼c c2007.
300 ▼a 204 p. : ▼b ill. ; ▼c 24 cm.
504 ▼a Includes bibliographical references and index.
505 0 ▼a The enormous initial mistake -- The origins of six sigma -- Evolution -- Revolution -- Paradox -- Action and reaction -- Close enough or on target? -- Make more-- faster! -- Case studies -- The camera always lies -- Keeping it simple -- Why use control charts? -- Average and range control charts -- Origins and theory -- Charts for individuals -- Practical considerations -- Improving laboratories -- Beyond compliance.
650 0 ▼a Drugs ▼x Quality control.
650 0 ▼a Six sigma (Quality control standard)
650 0 ▼a Pharmaceutical industry.
650 1 2 ▼a Drug Industry.
650 1 2 ▼a Technology, Pharmaceutical ▼x methods.
650 2 2 ▼a Efficiency, Organizational.
650 2 2 ▼a Quality Control.
700 1 ▼a McConnell, John S.
945 ▼a KINS

Holdings Information

No. Location Call Number Accession No. Availability Due Date Make a Reservation Service
No. 1 Location Science & Engineering Library/Sci-Info(Stacks2)/ Call Number 338.476151 N972s Accession No. 121158648 Availability Available Due Date Make a Reservation Service B M

Contents information

Table of Contents

The Enormous Initial Mistake Why? The Ultimate Curse A Metamorphosis is Possible The Enormous Initial Mistake The Origins of Six Sigma Genesis Understanding and Reducing Variation Understanding the Sigma Level Gaining Greatest Leverage Some Structural Elements of Six Sigma Conclusion Evolution In the Beginning… The Advent of Mass Production Illustrating Variation Revolution Is This Understanding Important? Stabilize First …Then Improve the Process The First Principle Deming Polishes the Diamond Deming’s First Opportunity Deming’s Second Opportunity The Deming Approach Limits to Knowledge Paradox How Do You Know? Improving the Analysis Detecting Instability Using Control Charts Chemical Example from the Pharmaceutical Industry Biological Example from the Pharmaceutical Industry Compliance Example from the Pharmaceutical Industry The Attributes or Binary Mindset Action and Reaction The Nelson Funnel (or Pen Dropping) Experiment Results of the Exercise Service Elements of the Pharmaceutical Industry Close Enough; … Or On Target? Make More…Faster! The Dice Experiment Little’s Law Quality Control Considerations Six Sigma and First Pass Yield Pharmaceutical Case Study ? Increasing Output Case Studies Biological Case Study ? Fermentation Parenterals Operation Case Study Safety Case Study Improved Control of Potency Deviations in a Pharmaceutical Plant The Camera Always Lies In God We Trust… How Exact is Exact? Giving Data Meaning Service Industries Keeping It Simple Time ? The First Imperative Pattern and Shape The DTLF Approach Why Use Control Charts? Why Use Control Charts? Types of Data Control Charts Advantages Developing Control Limits Average and Range Control Charts Constructing an Average and Range Control Chart How the Formulae Work Why the Chart Works Sub-Group Integrity Serial Sampling ? Loss of Sub-Group Integrity and Over-Control Origins and Theory Developing Control Limits Making the Control Chart Control Limits Vary with Sub-Group Size Specifications and Control Limits Why Use Averages? Interpreting the Charts The Final Word Appendix A Origins of the Formulae Charts for Individuals Constructing the Charts Interpreting Individual Point and Moving Range Charts Summary Stratification Pattern and Shape Periodicity Practical Considerations What Do the Statistics Mean? Rational Sub-Groups The Blessing of Chaos Stabilizing a Process Causal Relationships Process Control Eliminate Waste What to Measure and Plot Appendix A Example Operational Directive Improving Laboratories Production Lines are the Laboratory’s Customers Types of Methods Variability Estimates Understanding Capability Accuracy vs. Precision Use of Validation Data to Determine Laboratory Precision Reducing Variability ? More Is Not Always Better Appendix A Implementing a Laboratory Variability Reduction Project Appendix B Implementing a Blind Control Study Beyond Compliance We Have Met the Enemy, and He is Us Appendix 1 Factors for Estimating s from R? and s? Appendix 2 Factors for x? and R Control Charts Appendix 3 Factors for x? and s Control Charts


Information Provided By: : Aladin

New Arrivals Books in Related Fields

角川アスキー總合硏究所 (2023)
한국맥도날드 (2023)
SK 네트웍스 (2023)
국립민속박물관 (2023)